Aimy Palawooth is a Clinical Affairs Manager with FHI Clinical, based in Nakhon Si Thammarat Province, Thailand. Learn about how FHI Clinical serves rural-based employees and trial participants alike.
Andy brings his years of sales experience in the clinical research industry to his role in the FHI Clinical Client Solutions team. When he's not at work, he enjoys cycling with his wife, cooking, coffee and more.
Equity in research plays a vital role in equity in health and health care, starting with clinical trials and carrying through post-marketing access to new vaccines and treatments. Read this blog post for a deeper dive into where the industry stands with equitable access and how it contributes to the success of a trial.
From experiences such as working in Hawaii to attending the Billboard Music Awards, Nathan McKinney, Associate Director, Proposal Management, has refined an imperative quality for success.
Watch this episode of The Huxley Morton Podcast to hear our COO Rob King talk about how the skills he learned as a law enforcement officer working in the hostage and drug department help him excel in the clinical research industry.
Dissonance in regulatory processes and timelines between countries in Africa has been cited as a major deterrent to pursuing research in the area, but times are changing. Initiatives are successfully increasing regulatory harmonization and streamlining marketing authorization across the continent.
With experienced researchers and sites, investment in research infrastructure by local and overseas organizations as well as engaged stakeholders, Africa should be a research destination for pharma, biotech, government and non-governmental organizations alike.
One strategy to reaching endemic status for COVID-19 globally is equitable access to vaccines and therapies. Studies such as the one we're supporting in Ghana will help with this.
Although the diversity of Africa is often cited, the full extent is still not well understood. As we learn more, the true potential of the continent for clinical research to address ongoing public health issues becomes apparent.
The dynamic nature of infectious disease epidemiology requires diligent surveillance to ensure clinical trials of vaccines and treatments can successfully recruit and account for changing seroprevalence and new variants.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA